
Schrodinger, Inc. Common Stock
SDGR
SDGR: Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
moreShow SDGR Financials
Recent trades of SDGR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SDGR's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Binding affinity scoring with penalty for breaking conjugation between aromatic ligand groups Jan. 02, 2018
-
Patent Title: Binding affinity scoring function penalizing compounds which make unfavorable hydrophobic contacts with localized water molecules in the receptor active site Aug. 13, 2013
-
Patent Title: Predictive scoring function for estimating binding affinity Mar. 27, 2012
Federal grants, loans, and purchases
Followers on SDGR's company Twitter account
Number of mentions of SDGR in WallStreetBets Daily Discussion
Recent insights relating to SDGR
Recent picks made for SDGR stock on CNBC
ETFs with the largest estimated holdings in SDGR
Flights by private jets registered to SDGR